Clinical performance of two new, fully integrated molecular platforms used for HIV-1, HBV and HCV viral load analysis, the NeuMoDx 288 and the Alinity m.
Open Access
- 2 January 2023
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 160, 105376
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Multicenter clinical evaluation of alinity m HBV assay performanceJournal of Clinical Virology, 2020
- Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samplesJournal of Clinical Virology, 2020
- Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral loadJournal of Clinical Virology, 2017
- A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS ® TAQMAN ® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kitJournal of Clinical Virology, 2017
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infectionJournal of Hepatology, 2017
- Literature review of the distribution of hepatitis C virus genotypes across EuropeJournal of Medical Virology, 2016
- Comparing Abbott m2000 RealTime HIV test and Roche COBAS Ampliprep/COBAS Taqman HIV test, v2.0 in treated HIV‐1 B and non‐B subjects with low viraemiaJournal of Medical Virology, 2015
- HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemicsRetrovirology, 2013
- Comparison of Three Roche Hepatitis B Virus Viral Load Assay FormatsJournal of Clinical Microbiology, 2012
- Performance of the automated Abbott RealTime™ HIV-1 assay on a genetically diverse panel of specimens from BrazilJournal of Virological Methods, 2006